US2549303A - Inhaler for crystalline pencilllin or the like - Google Patents
Inhaler for crystalline pencilllin or the like Download PDFInfo
- Publication number
- US2549303A US2549303A US88504A US8850449A US2549303A US 2549303 A US2549303 A US 2549303A US 88504 A US88504 A US 88504A US 8850449 A US8850449 A US 8850449A US 2549303 A US2549303 A US 2549303A
- Authority
- US
- United States
- Prior art keywords
- unit
- tubular member
- wall
- inhaler
- rupturable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
- A61M15/0016—Details of inhalators; Constructional features thereof with inhalation check valves located downstream of the dispenser, i.e. traversed by the product
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
- A61M15/0036—Piercing means hollow piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Definitions
- This invention relates to devices for the inhalationof relatively dry powdered medicaments, 'such as crystalline penicillin.
- Inhalers constructed in accordance with this invention consist of two telescopically arranged basic units.
- One of the units is in the nature of a cartridge comprising a base, an upstanding, generally cylindrical tubular side wall that defines, with the base, a compartment for dry finely divided medicinal dust or powder, such as crystalline penicillin.
- a rupturable wall is disposed across the upper end of the tubular side wall to hermetically seal the medicinal powder within the compartment.”
- the second unit comprises a body having a downwardly projecting, preferably frusto-conical extension at its lower end and a depending flange or tubular wall concentric with and spaced from the extension.
- the unit is provided with a pas* sage extending through the body and its exten sion.
- the tubular side Wall of the first unit is inserted in the flange of the second unit with its rupturable top wall po sitioned below the extension and spaced slightly therefrom.
- the inhaler of this invention may have a single tip by which the medicament may be administered orally or through a nasal passage. It is within the purview of the invention to provide a pair of tips adapted, respectively, for nasal or oral administration, there being suitable valve means and associated devices for permitting the flow of air bearing the medicament through the selected tip.
- Another object of the invention is to provide an'inhaler for finely powdered medicament that is inexpensive in manufacturing cost.
- the invention has for another object the provision of an inhaler adapted to readily apply dry finely divided medicaments, such as crystalline penicillin, to the surfaces of respiratory passages, such as the throat, the bronchial tube, and nasal passages.
- dry finely divided medicaments such as crystalline penicillin
- Figure 1 is a view in elevation of one form of inhaler embodying the invention, the basic units thereof being shown in spaced-apart relation;
- Figure 2 is a central vertical cross-sectional view of the inhaler shown in Figure 1, with the parts assembled in one relative position;
- Figure 3 corresponds to Figure 2, and shows the parts in another relative position;
- Figure 4 is a view in side elevation of a modified form of the invention and corresponds generally to Figure 1;
- Figure 5 is a top plan view of the device shown in Figure 4.
- Figure 6 is a central cross-sectional view in enlargement of the inhaler of Figure 4, with the parts assembled in one relative position;
- Figure 7 is a view in enlargement taken along line 1--1 of Figure 6.
- the inhaler shown in Figures 1, 2 and 3 includes a first unit or cartridge III that comprises a circular base or bottom wall l2, having peripheral serrations, as indicated at I 4, to permit firm gripping by the user.
- a first unit or cartridge III Integral with the base is a generally cylindrical tubular side Wall l6, defining, with the base, a compartment 18' for containing a quantity of powdered medicament 20, such as crystalline penicillin.
- the base and tubular side wall are preferably formed of a suitable transparent plastic material that will not contaminate or adversely afiect the medicament contained therein.
- a rupturable diaphragm or top wall 22, made of a suitable rubber, plastic or the like, is disposed across the upper end of tubular side wall [6 and serves to hermetically seal the medicament within compartment l8.
- Unit 24 is also preferably made of a suitable plastic material.
- Unit 24 comprises a body 26, rounded at its upper end or tip to permit insertion in a nostril or in the mouth of a user and having a downwardly tapering *frusto-conical extension 28 at its lower end.
- an upwardly flaring central passage 30 extends through body 26 and its extension 28.
- Integral with body 26 is a depending flange or tubular member 32 that is concentric with and spaced from extension 28 and projects below the end of the extension.
- a plurality of angularly spaced grooves 34 are formed along the inner surface of tubular member 32 and connect with corresponding grooves 36 in the bottom of body 23, thereby establishing communication between the exterior of the device and the space between tubular member 32 and extension 28 when the parts are in assembled position.
- Tubular wall 16 is partly disposed in tubular member 32, there being sufficient frictional engagement between these elements to maintain the units in the relative position shown in Figure 2.
- the peripheral surface of tubular member l6 and/or the inner surface of tub ular member 32 is tapered slightly.
- units l and 24 may be separated by exerting sufi'lcient pull to overcome the friction between the units.
- unit ll may be protracted with respect to unit 24-; that is, moved from the position shown in Figure 2 to that shown in Figure 3. This causes frusto-conical extension 28 to pierce rupturable wall 22 and enter compartment !8.
- the parts having assumed the position shown in Figure 3, the upper end of body 23 is inserted in the 'mouth or in a nostril of theuser.
- the user exhales and then inserts the tip end of body 26 into one nostril and closesthe other nostril by fingerpressure.
- the user then inhales slowly and deeply through his nose, drawing in a quantity of air and medicament through passage 35 in the same manner as outlined above in connection with oral administration of the medicament.
- the form of the invention shown in Figures 4-7 i similar in a number of respects to that shown in Figures 1, 2 and 3, and includes a cartridge I! that is preferably the same as the earlier described cartridge.
- the inhaler of Figures fi-T includes a second unit 38 comprising a body 39 having a pair of divergent upper ex tensionsM and 42.
- Extension 40 is generally circular in cross section and is intended for insertion in a nostril.
- Extension '42 is generally elliptical in cross section and is intended to be inserted in the mouth.
- Body 39 is provided with a frusto-conical extension it and a depending circular flange or tubular member 46 that are preferably the same, in configuration and relativeposition, as extension 28 and tubular member 32 of the previously described form of the invention. Body 39 is also provided with a pair of oppositely disposed external depressions 48 to accommodate a user's fingers. v
- a central blind bore 50 extends through extension 44 and terminates in body 39.
- a passage 52 communicates with bore 50 'and extends through extension 48. This passage consists of a lower portion of reduced diameter 54' and an upper portion of enlarged diameter 56 that is tapped at its outer end.
- a valve seat 58 is provided at the juncture of passage portions 54 and 56 for a ball check valve 60.
- a threaded plug 62 is positioned in the tapped end of extension 40 and has a central passage 64 establishing communication between passage 52 and the exterior of unit 38-.
- Plug 52 is provided at its outer end with a screw driver slot 66 to permit or its ready insertion or removal, and at its inner end with cross slots 68 ( Figure '7) to permit outward flow of air at such times as ball valve 58 may be disposed across the inner end of passage 64.
- Unit 38 is provided with another passage 10 corresponding to passage 52.
- Passage 10 communicates with bore 55 and extends through end portion 52 of body 39.
- valve seat l2 Within passage 10 are a valve seat l2, a ball valve 14 and a threaded plug 16 which are the same as valve seat 58, ball valve 59 and plug 62, earlier described.
- Units IE3 and 38 are assembled and maintained in assembled position in the same manner as outlined above in connection with the form of the invention shown in Figures 1, 2 and 3
- the user grips unit [0 with the fingersof one hand and unit 38 with the fingers of his other hand, and effects protraction of unit H] with respect to unit 38, thereby piercing rupturable wall 22 ( Figure 6).
- extension ll in a nostril and inhales through that nostril, drawing air through recesses 18 and at, which air picks up particles of the medicament and then passes's, with the entrained medicament, upwardly through bore 56, passage 52, past ball valve til andth-rough passage 3 3.
- ball valve H? is seated on its seat 12. Itit isdecided to administer the medicament orally, the user inserts extension 42 in his mouth and inhales through the mouth, air from the atmosphere and medicament entrained therein from compartment l8 flowing upwardly through bore 50, along passage '10, past valve 14, andthen through the passage in plug 16. It will be apparent that at such times, valve 66 remains on its seat 58.
- first unit for containing crystalline penicillin or the like, said first 'unit comprising a bottom wall, a tubular side wall and a ruptu'rableto'p wall hermetically sealing the penicillin "within ithe'uni't
- second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extendin below the lower end or the body, an "element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element
- said second unit having -'a passage extending through the body and the element 'fo'i' ass- 08 establishing communication between the interior of the tubular member and the exterior of the body in the region ofthe upper end of the body, and means establishing communication between the exterior of the units and the space
- a hollow first unit for. cone taining crystalline penicillin or the like said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit
- a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, a downwardly tapering element carried by the body and projecting within the tubular member, said element being concentric with and spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element
- said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, and means establishing communication between the exterior of the units and the space between the element and the tubular member.
- a hollow first unit for containing crystalline penicillin or the like said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit
- a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced.
- tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element
- said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, said units defining a passage establishing communication between the exterior thereof and the space between the element and the tubular member.
- a hollow first unit for containing crystalline penicillin or the like said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit
- a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, a downwardly tapering element carried by the body and projecting within the tubular member, said element being concentric with and spaced from the tubular member, said tubular side wall being partly disposed within and frictionally engaging the inner surface of the tubular member with the rupturable wall positioned below the element
- said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, said units defining a passage establishing communi cation between the exterior. thereof and the space between the element and the tubular member.
- a hollow first unit for containing crystalline penicillin or the like said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit
- a second unit comprising anelongated body rounded at its upper end for insertion in a respiratory orifice, said body carrying an integral depending fiangeand a concentric frusto-conical extension at its lower end, said extension being positioned within and spaced from the flange, said body and extension having a central through passage, said second unit having at least one recessformed along the interior of the flange and the under surface of the body, said recess originatingat the lower end of the flange and terminating inwardly thereof, the units being telescopically arranged with the'tubular side wall of the first unit positioned partly within the flange of the second unit and with the rupturable top Wall directly below the extension.
- a hollow first unit for containing crystalline penicillin or the like said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit
- a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in a nostril and in the mouth, respectively, a tubular member integral with and extending below the lower end of the body, and an element carried by the body for rupturing the rupturable wall
- said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a, corresponding extension, and means establishing communication between the exterior of the units and the space between the element and the tubular member.
- a hollow first unit for containing crystalline penicillin or the like said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit
- a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in a nostril and in the mouth, respectively, a tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a corresponding extension, and a check valve in each of the pair of passages, each check valve permitting fluid flow upwardly through the bore and then through a corresponding passage while preventing fluid flow in a reverse direction
- a hollow first unit for containing crystalline penicillin or the like comprising a, bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in 2.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
133551 .1; H FRED-EN 2,549,303
EUR PENIGILLIN OR THE Filed April 2c 1949 K I 3s I lllllll! lllllllllllillllllllll INVEN TOR.
JOHN. H. F RIDEN ATTORNEY.
Patented Apr. 17, 1951 OR THE LIKE John H. Friden, Maplewood, N. J., assignor to Bristol Laboratories, Inc., Syracuse, N. Y., a
corporation of New York Application April 20, 1949, Serial No. 88,504
This invention relates to devices for the inhalationof relatively dry powdered medicaments, 'such as crystalline penicillin.
Inhalers constructed in accordance with this invention consist of two telescopically arranged basic units. One of the units is in the nature of a cartridge comprising a base, an upstanding, generally cylindrical tubular side wall that defines, with the base, a compartment for dry finely divided medicinal dust or powder, such as crystalline penicillin. A rupturable wall is disposed across the upper end of the tubular side wall to hermetically seal the medicinal powder within the compartment." l
The second unit comprises a body having a downwardly projecting, preferably frusto-conical extension at its lower end and a depending flange or tubular wall concentric with and spaced from the extension. The unit is provided with a pas* sage extending through the body and its exten sion. At the time of assembly, the tubular side Wall of the first unit is inserted in the flange of the second unit with its rupturable top wall po sitioned below the extension and spaced slightly therefrom.
-As will be explained in detail further along, the inhaler of this invention may have a single tip by which the medicament may be administered orally or through a nasal passage. It is within the purview of the invention to provide a pair of tips adapted, respectively, for nasal or oral administration, there being suitable valve means and associated devices for permitting the flow of air bearing the medicament through the selected tip.
It is the primary object of the invention to pro vide an inhaler for crystalline penicillin'or the like that is simple and compact in construction and capable of accomplishing its intended functions in an efiicient and trouble-free manner.
Another object of the invention is to provide an'inhaler for finely powdered medicament that is inexpensive in manufacturing cost.
The invention has for another object the provision of an inhaler adapted to readily apply dry finely divided medicaments, such as crystalline penicillin, to the surfaces of respiratory passages, such as the throat, the bronchial tube, and nasal passages.
The foregoing objects, as well as other objects, together with the advantages of the invention, will be' readily understood by persons skilled in the art upon reference to the following detailed description, taken in conjunction with the annexed drawing, which respectively describe and 9 Claims. (Cl. 128-206) illustrate preferred forms of inhalers constructed in accordance with the invention.
In the drawing: Figure 1 is a view in elevation of one form of inhaler embodying the invention, the basic units thereof being shown in spaced-apart relation;
Figure 2 is a central vertical cross-sectional view of the inhaler shown in Figure 1, with the parts assembled in one relative position; Figure 3 corresponds to Figure 2, and shows the parts in another relative position;
Figure 4 is a view in side elevation of a modified form of the invention and corresponds generally to Figure 1;
Figure 5 is a top plan view of the device shown in Figure 4;
Figure 6 is a central cross-sectional view in enlargement of the inhaler of Figure 4, with the parts assembled in one relative position; and
Figure 7 is a view in enlargement taken along line 1--1 of Figure 6.
Referring now to the drawing, wherein like reference numerals denote corresponding parts throughout the several views, the inhaler shown in Figures 1, 2 and 3 includes a first unit or cartridge III that comprises a circular base or bottom wall l2, having peripheral serrations, as indicated at I 4, to permit firm gripping by the user. Integral with the base is a generally cylindrical tubular side Wall l6, defining, with the base, a compartment 18' for containing a quantity of powdered medicament 20, such as crystalline penicillin. The base and tubular side wall are preferably formed of a suitable transparent plastic material that will not contaminate or adversely afiect the medicament contained therein. A rupturable diaphragm or top wall 22, made of a suitable rubber, plastic or the like, is disposed across the upper end of tubular side wall [6 and serves to hermetically seal the medicament within compartment l8.
Mounted on and frictionally engaging cartridge III is a second unit 24, which is also preferably made of a suitable plastic material. Unit 24 comprises a body 26, rounded at its upper end or tip to permit insertion in a nostril or in the mouth of a user and having a downwardly tapering *frusto-conical extension 28 at its lower end. As is best shown in Figures 2 and 3, an upwardly flaring central passage 30 extends through body 26 and its extension 28. Integral with body 26 is a depending flange or tubular member 32 that is concentric with and spaced from extension 28 and projects below the end of the extension. A plurality of angularly spaced grooves 34 are formed along the inner surface of tubular member 32 and connect with corresponding grooves 36 in the bottom of body 23, thereby establishing communication between the exterior of the device and the space between tubular member 32 and extension 28 when the parts are in assembled position.
For administration of the medicament through the mouth, air is first expelled from the lungs and the upper or tipend of body 26 is inserted between the lips and the lips are compressed. The user then inhales slowly and deeply through the mouth. This causes aspiration of air through the passages formed by recesses 34 and 36, the picking up of the particles of the medicament by the air, and the flow of the air and entrained medicament through passage 38 and thence into the mouth and communicating respiratory passages.
If adminstration is to be made through the nose, the user exhales and then inserts the tip end of body 26 into one nostril and closesthe other nostril by fingerpressure. The user then inhales slowly and deeply through his nose, drawing in a quantity of air and medicament through passage 35 in the same manner as outlined above in connection with oral administration of the medicament.
The form of the invention shown in Figures 4-7 i similar in a number of respects to that shown in Figures 1, 2 and 3, and includes a cartridge I!) that is preferably the same as the earlier described cartridge. The inhaler of Figures fi-T includes a second unit 38 comprising a body 39 having a pair of divergent upper ex tensionsM and 42. Extension 40 is generally circular in cross section and is intended for insertion in a nostril. Extension '42 is generally elliptical in cross section and is intended to be inserted in the mouth.
A central blind bore 50 extends through extension 44 and terminates in body 39. A passage 52 communicates with bore 50 'and extends through extension 48. This passage consists of a lower portion of reduced diameter 54' and an upper portion of enlarged diameter 56 that is tapped at its outer end. A valve seat 58 is provided at the juncture of passage portions 54 and 56 for a ball check valve 60. A threaded plug 62 is positioned in the tapped end of extension 40 and has a central passage 64 establishing communication between passage 52 and the exterior of unit 38-. Plug 52 is provided at its outer end with a screw driver slot 66 to permit or its ready insertion or removal, and at its inner end with cross slots 68 (Figure '7) to permit outward flow of air at such times as ball valve 58 may be disposed across the inner end of passage 64.
Units IE3 and 38 are assembled and maintained in assembled position in the same manner as outlined above in connection with the form of the invention shown in Figures 1, 2 and 3 Preparatory to using the inhaler shown in Figures 2-7, the user grips unit [0 with the fingersof one hand and unit 38 with the fingers of his other hand, and effects protraction of unit H] with respect to unit 38, thereby piercing rupturable wall 22 (Figure 6). It it is desired -to administer the powdered medicament nasally, the user inserts extension ll] in a nostril and inhales through that nostril, drawing air through recesses 18 and at, which air picks up particles of the medicament and then passe's, with the entrained medicament, upwardly through bore 56, passage 52, past ball valve til andth-rough passage 3 3. During nasal administration, ball valve H? is seated on its seat 12. Itit isdecided to administer the medicament orally, the user inserts extension 42 in his mouth and inhales through the mouth, air from the atmosphere and medicament entrained therein from compartment l8 flowing upwardly through bore 50, along passage '10, past valve 14, andthen through the passage in plug 16. It will be apparent that at such times, valve 66 remains on its seat 58.
From the foregoing, it is believed that the construction, operation and advantages of my present invention will be readily comprehended by persons skilled in the art. It is to be clearly understood, however, that the forms of the in vention herewith shown and described are be taken as preferred examples of the same, and that various changes in the shape, size and arrangement of parts may be resorted to without departing from the spirit of the invention as defined by the appended claims.
I claim:
1. In an inhaler, 'a hollow first unit for containing crystalline penicillin or the like, said first 'unit comprising a bottom wall, a tubular side wall and a ruptu'rableto'p wall hermetically sealing the penicillin "within ithe'uni't, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extendin below the lower end or the body, an "element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having -'a passage extending through the body and the element 'fo'i' ass- 08 establishing communication between the interior of the tubular member and the exterior of the body in the region ofthe upper end of the body, and means establishing communication between the exterior of the units and the space between the element and the tubular member.
2. In an inhaler, a hollow first unit for. cone taining crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, a downwardly tapering element carried by the body and projecting within the tubular member, said element being concentric with and spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, and means establishing communication between the exterior of the units and the space between the element and the tubular member.
3. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced. from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, said units defining a passage establishing communication between the exterior thereof and the space between the element and the tubular member.
4. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having an upper end adapted to be inserted in a respiratory orifice, a tubular member integral with and extending below the lower end of the body, a downwardly tapering element carried by the body and projecting within the tubular member, said element being concentric with and spaced from the tubular member, said tubular side wall being partly disposed within and frictionally engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a passage extending through the body and the element for establishing communication between the interior of the tubular member and the exterior of the body in the region of the upper end of the body, said units defining a passage establishing communi cation between the exterior. thereof and the space between the element and the tubular member.
5. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising anelongated body rounded at its upper end for insertion in a respiratory orifice, said body carrying an integral depending fiangeand a concentric frusto-conical extension at its lower end, said extension being positioned within and spaced from the flange, said body and extension having a central through passage, said second unit having at least one recessformed along the interior of the flange and the under surface of the body, said recess originatingat the lower end of the flange and terminating inwardly thereof, the units being telescopically arranged with the'tubular side wall of the first unit positioned partly within the flange of the second unit and with the rupturable top Wall directly below the extension.
6. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in a nostril and in the mouth, respectively, a tubular member integral with and extending below the lower end of the body, and an element carried by the body for rupturing the rupturable wall,
I said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a, corresponding extension, and means establishing communication between the exterior of the units and the space between the element and the tubular member.
7. In an inhaler, a hollow first unit for containing crystalline penicillin or the like, said first unit comprising a bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in a nostril and in the mouth, respectively, a tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a corresponding extension, and a check valve in each of the pair of passages, each check valve permitting fluid flow upwardly through the bore and then through a corresponding passage while preventing fluid flow in a reverse direction, and means establishing communication between the exterior of the units and the space between the element and the tubular member.
8. In an inhaler, a hollow first unit for containing crystalline penicillin or the like,- said first unit comprising a, bottom wall, a tubular side wall and a rupturable top wall hermetically sealing the penicillin within the unit, a second unit comprising a body having a pair of divergent upper extensions adapted for insertion in 2. nostril and in the mouth, respectively, a, tubular member integral with and extending below the lower end of the body, an element carried by the body for rupturing the rupturable wall, said element projecting within and being spaced from the tubular member, said tubular side wall being partly disposed within and engaging the inner surface of the tubular member with the rupturable wall positioned below the element, said second unit having a bore extending through the element and a pair of passages respectively communicating with the bore and extending through a corresponding extension, a ball check valve in each of the pair of passages, each ball check valve permitting fluid flow upwardly through the bore and then through a corresponding passage while preventing fluid flow in a reverse direction, and a removable plug at the free end of each extension, each plug having an opening establishing communication between the corresponding one of said pair of passages and the exterior of the extension said units defining a passage establishing communication be= tween the exterior thereof and the space between the element and the tubular member.
9. An inhaler in accordance with claim 8, wherein the element is frusto-conical and concentric with the tubular member and the tubular side wall frictionally engages the inner sur-' face of the tubular member.
JOHN H. FRIDEN.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name Date 2,307,986 Bolte Jan. 12, 1943 2,478,715 Sehmitt Aug. 9, 1949'
Claims (1)
- 2. IN AN INHALER, A HOLLOW FIRST UNIT FOR CONTAINING CRYSTALLINE PENICILLIN OR THE LIKE, SAID FIRST UNITL COMPRISING A BOTTOM WALL, A TUBULAR SIDE WALL AND A RUPTURABLE TOP WALL HERMETICALLY SEALING THE PENICILLIN WITHIN THE UNIT, A SECOND UNIT COMPRISING A BODY HAVING AN UPPER END ADAPTED TO BE INSERTED IN A RESPIRATORY ORIFICE, A TUBULAR MEMBER INTEGRAL WITH AND EXTENDING BELOW THE LOWER END OF THE BODY, A DOWNWARDLY TAPERING ELEMENT CARRIED BY THE BODY AND PROJECTING WITHIN THE TUBULAR MEMBER, SAID ELEMENT BEING CONCENTRIC WITH AND SPACED FROM THE TUBULAR MEMBER, SAID TUBULAR SIDE WALL BEING PARTLY DISPOSED WITHIN AND ENGAGING THE INNER SURFACE OF THE TUBULAR MEMBER WITH THE RUPTURABLE WALL POSITIONED BELOW THE ELEMENT, SAID SECOND UNTIL HAVING A PASSAGE EXTENDING THROUGH THE BODY AND THE ELEMENT FOR ESTABLISHING THROUGH MUNICATION BETWEEN THE INTERIOR OF THE TUBULAR MEMBER AND THE EXTERIOR OF THE BODY IN THE REGION OF THE UPPER END OF THE BODY, AND MEANS ESTABLISHING COMMUNICATION BETWEEN THE EXTERIOR OF THE UNITS AND THE SPACE BETWEEN THE ELEMENT AND THE TUBULAR MEMBER.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88504A US2549303A (en) | 1949-04-20 | 1949-04-20 | Inhaler for crystalline pencilllin or the like |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88504A US2549303A (en) | 1949-04-20 | 1949-04-20 | Inhaler for crystalline pencilllin or the like |
Publications (1)
Publication Number | Publication Date |
---|---|
US2549303A true US2549303A (en) | 1951-04-17 |
Family
ID=22211757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US88504A Expired - Lifetime US2549303A (en) | 1949-04-20 | 1949-04-20 | Inhaler for crystalline pencilllin or the like |
Country Status (1)
Country | Link |
---|---|
US (1) | US2549303A (en) |
Cited By (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3400714A (en) * | 1965-05-03 | 1968-09-10 | Brunswick Corp | Nasal cannula |
US4005711A (en) * | 1975-01-13 | 1977-02-01 | Syntex Puerto Rico, Inc. | Inhalation device |
US4064878A (en) * | 1975-06-13 | 1977-12-27 | Syntex Puerto Rico, Inc. | Inhalation device |
US4095596A (en) * | 1976-11-26 | 1978-06-20 | Smithkline Corporation | Nasal inhaler |
US5161524A (en) * | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
US5349947A (en) * | 1993-07-15 | 1994-09-27 | Newhouse Michael T | Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow |
US5355873A (en) * | 1990-07-27 | 1994-10-18 | Bon F Del | An inhalation device and method having a variably restrictable air inlet that allows the inhalation force required to overcome a locking element to be changed |
US5388573A (en) * | 1993-12-02 | 1995-02-14 | Tenax Corporation | Dry powder inhalator medicament carrier |
US5388572A (en) * | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
US5460173A (en) * | 1993-03-03 | 1995-10-24 | Tenax Corporation | Dry powder inhaler medicament carrier |
US5483954A (en) * | 1994-06-10 | 1996-01-16 | Mecikalski; Mark B. | Inhaler and medicated package |
US5533502A (en) * | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
US5533505A (en) * | 1992-03-04 | 1996-07-09 | Astra Aktiebolag | Disposable inhaler |
USD381416S (en) * | 1996-02-08 | 1997-07-22 | Astra Aktiebolag | Unit dose inhaler |
US5660169A (en) * | 1990-09-12 | 1997-08-26 | Astra Aktiebolag | Disposable inhaler with pull-off seal |
US5669378A (en) * | 1995-12-21 | 1997-09-23 | Pera; Ivo | Inhaling device |
US5673686A (en) * | 1994-02-02 | 1997-10-07 | Plurichemie Anstalt | Medicament inhaler and method |
WO1997040876A2 (en) * | 1996-04-25 | 1997-11-06 | Alfred Von Schuckmann | Inhaler |
EP0846009A1 (en) * | 1994-09-21 | 1998-06-10 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
WO1999066974A2 (en) * | 1998-06-22 | 1999-12-29 | Astrazeneca Ab | Device for emptying cavities containing powder by means of suction |
US6055979A (en) * | 1996-04-02 | 2000-05-02 | Ing. Erich Pfeiffer Gmbh | Dosing and discharging device for flowable media including powder/air dispersions |
US6102036A (en) * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
US6234169B1 (en) * | 1998-08-14 | 2001-05-22 | Arthur Slutsky | Inhaler |
US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US6651341B1 (en) * | 2000-09-25 | 2003-11-25 | Microdrug Ag | Foil cutter |
US6679256B2 (en) | 1999-12-17 | 2004-01-20 | Nektar Therapeutics | Systems and methods for extracting powders from receptacles |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
WO2004012802A1 (en) * | 2002-08-05 | 2004-02-12 | Budai Laszlo | Inhaler apparatus for mitigating respiratory complaints |
US20040182387A1 (en) * | 1999-07-23 | 2004-09-23 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US20040219206A1 (en) * | 1994-12-02 | 2004-11-04 | Roser Bruce J. | Solid dose delivery vehicle and methods of making same |
US20050121032A1 (en) * | 2003-12-03 | 2005-06-09 | Microdrug Ag | Pre-metered dry powder inhaler for moisture-sensitive medicaments |
US20050279349A1 (en) * | 1991-07-02 | 2005-12-22 | Patton John S | Method and device for delivering aerosolized medicaments |
KR100581631B1 (en) * | 1998-06-22 | 2006-05-23 | 아스트라제네카 아베 | Device to empty the powder storage cavity by suction |
US20070209661A1 (en) * | 2006-03-03 | 2007-09-13 | Hugh Smyth | Dry powder inhaler with aeroelastic dispersion mechanism |
US20070267032A1 (en) * | 2003-11-18 | 2007-11-22 | Yansong Shan | Healthy Pleasurable Inhalation Device |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
US20080092887A1 (en) * | 2004-12-07 | 2008-04-24 | Hodson Peter D | Single-Dose Inhalation Devices |
US20090241949A1 (en) * | 2008-03-27 | 2009-10-01 | Smutney Chad C | Dry powder inhalation system |
US20090308390A1 (en) * | 2008-06-13 | 2009-12-17 | Smutney Chad C | Dry Powder Inhaler and System for Drug Delivery |
US20100197565A1 (en) * | 2008-06-13 | 2010-08-05 | Smutney Chad C | Dry powder drug delivery system |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
US9220687B2 (en) | 2008-12-29 | 2015-12-29 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9233159B2 (en) | 2011-10-24 | 2016-01-12 | Mannkind Corporation | Methods and compositions for treating pain |
US9241903B2 (en) | 2006-02-22 | 2016-01-26 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US9346766B2 (en) | 2004-08-20 | 2016-05-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9358352B2 (en) | 2008-06-13 | 2016-06-07 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US20170128679A1 (en) * | 2014-06-27 | 2017-05-11 | Sergio BELFORTI | A powder inhaler device |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9801925B2 (en) | 1999-06-29 | 2017-10-31 | Mannkind Corporation | Potentiation of glucose elimination |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US9943571B2 (en) | 2008-08-11 | 2018-04-17 | Mannkind Corporation | Use of ultrarapid acting insulin |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US10441733B2 (en) | 2012-06-25 | 2019-10-15 | Respira Therapeutics, Inc. | Powder dispersion devices and methods |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US20210016024A1 (en) * | 2018-04-16 | 2021-01-21 | Emphasys Importadora Exportadora E Distribuidora Ltda. | Dry Powder Inhaler |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
US11471623B2 (en) | 2012-02-21 | 2022-10-18 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
USD1038374S1 (en) * | 2021-08-31 | 2024-08-06 | Nemera La Verpilliere | Nasal spray device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2307986A (en) * | 1940-02-15 | 1943-01-12 | Bolte | Insufflator |
US2478715A (en) * | 1948-07-14 | 1949-08-09 | Vilbiss Co | Powder blower |
-
1949
- 1949-04-20 US US88504A patent/US2549303A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2307986A (en) * | 1940-02-15 | 1943-01-12 | Bolte | Insufflator |
US2478715A (en) * | 1948-07-14 | 1949-08-09 | Vilbiss Co | Powder blower |
Cited By (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3400714A (en) * | 1965-05-03 | 1968-09-10 | Brunswick Corp | Nasal cannula |
US4005711A (en) * | 1975-01-13 | 1977-02-01 | Syntex Puerto Rico, Inc. | Inhalation device |
US4098273A (en) * | 1975-01-13 | 1978-07-04 | Syntex Puerto Rico, Inc. | Inhalation device |
US4064878A (en) * | 1975-06-13 | 1977-12-27 | Syntex Puerto Rico, Inc. | Inhalation device |
US4105027A (en) * | 1975-06-13 | 1978-08-08 | Syntex Puerto Rico, Inc. | Inhalation device |
US4095596A (en) * | 1976-11-26 | 1978-06-20 | Smithkline Corporation | Nasal inhaler |
US5355873A (en) * | 1990-07-27 | 1994-10-18 | Bon F Del | An inhalation device and method having a variably restrictable air inlet that allows the inhalation force required to overcome a locking element to be changed |
US5660169A (en) * | 1990-09-12 | 1997-08-26 | Astra Aktiebolag | Disposable inhaler with pull-off seal |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
US20050279349A1 (en) * | 1991-07-02 | 2005-12-22 | Patton John S | Method and device for delivering aerosolized medicaments |
US5161524A (en) * | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
US5533505A (en) * | 1992-03-04 | 1996-07-09 | Astra Aktiebolag | Disposable inhaler |
US5460173A (en) * | 1993-03-03 | 1995-10-24 | Tenax Corporation | Dry powder inhaler medicament carrier |
US5533502A (en) * | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
US5349947A (en) * | 1993-07-15 | 1994-09-27 | Newhouse Michael T | Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow |
US5388572A (en) * | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
US5388573A (en) * | 1993-12-02 | 1995-02-14 | Tenax Corporation | Dry powder inhalator medicament carrier |
US5673686A (en) * | 1994-02-02 | 1997-10-07 | Plurichemie Anstalt | Medicament inhaler and method |
US6102036A (en) * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
US5575281A (en) * | 1994-06-10 | 1996-11-19 | Mecikalski; Mark B. | Medicated package |
US5483954A (en) * | 1994-06-10 | 1996-01-16 | Mecikalski; Mark B. | Inhaler and medicated package |
US5568807A (en) * | 1994-06-10 | 1996-10-29 | Mecikalski; Mark B. | Air-flow control for an inhaler |
CN1131080C (en) * | 1994-09-21 | 2003-12-17 | 吸入治疗系统 | Method and apparatus for dispersing dry powder medicaments |
EP0846009A1 (en) * | 1994-09-21 | 1998-06-10 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
AU697676B2 (en) * | 1994-09-21 | 1998-10-15 | Nektar Therapeutics | Apparatus and methods for dispersing dry powder medicaments |
EP0846009A4 (en) * | 1994-09-21 | 1999-07-28 | Inhale Therapeutic Syst | DEVICE AND METHOD FOR DISPERSING DRY POWDER MEDICINES |
US6543448B1 (en) | 1994-09-21 | 2003-04-08 | Inhale Therapeutic Systems, Inc. | Apparatus and methods for dispersing dry powder medicaments |
US6089228A (en) * | 1994-09-21 | 2000-07-18 | Inhale Therapeutic Systems | Apparatus and methods for dispersing dry powder medicaments |
US7780991B2 (en) | 1994-12-02 | 2010-08-24 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
US7785631B2 (en) | 1994-12-02 | 2010-08-31 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
US20040219206A1 (en) * | 1994-12-02 | 2004-11-04 | Roser Bruce J. | Solid dose delivery vehicle and methods of making same |
US7744925B2 (en) | 1994-12-02 | 2010-06-29 | Quadrant Drug Delivery Limited | Solid dose delivery vehicle and methods of making same |
US5669378A (en) * | 1995-12-21 | 1997-09-23 | Pera; Ivo | Inhaling device |
USD381416S (en) * | 1996-02-08 | 1997-07-22 | Astra Aktiebolag | Unit dose inhaler |
US6055979A (en) * | 1996-04-02 | 2000-05-02 | Ing. Erich Pfeiffer Gmbh | Dosing and discharging device for flowable media including powder/air dispersions |
WO1997040876A3 (en) * | 1996-04-25 | 1998-01-15 | Schuckmann Alfred Von | Inhaler |
US6401712B1 (en) | 1996-04-25 | 2002-06-11 | Astrazeneca Ab | Inhaler |
AU720813B2 (en) * | 1996-04-25 | 2000-06-15 | Astrazeneca Ab | Inhaler |
WO1997040876A2 (en) * | 1996-04-25 | 1997-11-06 | Alfred Von Schuckmann | Inhaler |
US6546929B2 (en) | 1998-06-04 | 2003-04-15 | Inhale Therapeutic Systems, Inc. | Dry powder dispersing apparatus and methods for their use |
US20030209243A1 (en) * | 1998-06-04 | 2003-11-13 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US20080230058A1 (en) * | 1998-06-04 | 2008-09-25 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US8161969B2 (en) | 1998-06-04 | 2012-04-24 | Novartis Ag | Dry powder dispersing apparatus and methods for their use |
US7422013B2 (en) | 1998-06-04 | 2008-09-09 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US6901929B2 (en) | 1998-06-04 | 2005-06-07 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US6722363B1 (en) | 1998-06-22 | 2004-04-20 | Astrazeneca Ab | Device for emptying cavities containing powder by means of suction |
CN100371037C (en) * | 1998-06-22 | 2008-02-27 | 阿斯特拉曾尼卡有限公司 | Device for emptying cavities contg. powder by means of suction |
WO1999066974A3 (en) * | 1998-06-22 | 2000-05-04 | Schuckmann Alfred Von | Device for emptying cavities containing powder by means of suction |
CZ300314B6 (en) * | 1998-06-22 | 2009-04-15 | Astrazeneca Ab | Device for emptying powder-containing cavities |
KR100581631B1 (en) * | 1998-06-22 | 2006-05-23 | 아스트라제네카 아베 | Device to empty the powder storage cavity by suction |
WO1999066974A2 (en) * | 1998-06-22 | 1999-12-29 | Astrazeneca Ab | Device for emptying cavities containing powder by means of suction |
AU753094B2 (en) * | 1998-06-22 | 2002-10-10 | Astrazeneca Ab | Device for emptying cavities containing powder by means of suction |
US6234169B1 (en) * | 1998-08-14 | 2001-05-22 | Arthur Slutsky | Inhaler |
US9801925B2 (en) | 1999-06-29 | 2017-10-31 | Mannkind Corporation | Potentiation of glucose elimination |
US8156936B2 (en) | 1999-07-23 | 2012-04-17 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US20080053437A1 (en) * | 1999-07-23 | 2008-03-06 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
US20080127970A1 (en) * | 1999-07-23 | 2008-06-05 | Mannkind Corporation | Unit Dose Capsules and Dry Powder Inhaler |
US20080190425A1 (en) * | 1999-07-23 | 2008-08-14 | Steiner Solomon S | Unit dose cartridge and dry powder inhaler |
US8146588B2 (en) | 1999-07-23 | 2012-04-03 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US8950397B2 (en) | 1999-07-23 | 2015-02-10 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US9061111B2 (en) | 1999-07-23 | 2015-06-23 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US8215300B2 (en) | 1999-07-23 | 2012-07-10 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US8671937B2 (en) | 1999-07-23 | 2014-03-18 | Mannkind Corporation | Unit dose capsules and dry powder inhaler |
US20040182387A1 (en) * | 1999-07-23 | 2004-09-23 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US6679256B2 (en) | 1999-12-17 | 2004-01-20 | Nektar Therapeutics | Systems and methods for extracting powders from receptacles |
US6651341B1 (en) * | 2000-09-25 | 2003-11-25 | Microdrug Ag | Foil cutter |
US9700690B2 (en) | 2002-03-20 | 2017-07-11 | Mannkind Corporation | Inhalation apparatus |
WO2004012802A1 (en) * | 2002-08-05 | 2004-02-12 | Budai Laszlo | Inhaler apparatus for mitigating respiratory complaints |
WO2005023348A3 (en) * | 2003-09-04 | 2005-05-26 | Mannkind Corp | Unit dose cartridge and dry powder inhaler |
CN1859938B (en) * | 2003-09-04 | 2010-10-13 | 曼恩坎德公司 | Unit dose cartridge and dry powder inhaler |
US20070267032A1 (en) * | 2003-11-18 | 2007-11-22 | Yansong Shan | Healthy Pleasurable Inhalation Device |
US20090188495A1 (en) * | 2003-12-03 | 2009-07-30 | Boehringer Ingelheim International Gmbh | Pre-metered dry powder inhaler for moisture-sensitive medicaments |
US20050121032A1 (en) * | 2003-12-03 | 2005-06-09 | Microdrug Ag | Pre-metered dry powder inhaler for moisture-sensitive medicaments |
US9796688B2 (en) | 2004-08-20 | 2017-10-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US9346766B2 (en) | 2004-08-20 | 2016-05-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
US10130685B2 (en) | 2004-08-23 | 2018-11-20 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US9675674B2 (en) | 2004-08-23 | 2017-06-13 | Mannkind Corporation | Diketopiperazine salts for drug delivery and related methods |
US20080092887A1 (en) * | 2004-12-07 | 2008-04-24 | Hodson Peter D | Single-Dose Inhalation Devices |
US9717689B2 (en) | 2005-09-14 | 2017-08-01 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US10143655B2 (en) | 2005-09-14 | 2018-12-04 | Mannkind Corporation | Method of drug formulation |
US9446001B2 (en) | 2005-09-14 | 2016-09-20 | Mannkind Corporation | Increasing drug affinity for crystalline microparticle surfaces |
US9283193B2 (en) | 2005-09-14 | 2016-03-15 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
US10130581B2 (en) | 2006-02-22 | 2018-11-20 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US9241903B2 (en) | 2006-02-22 | 2016-01-26 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US20070209661A1 (en) * | 2006-03-03 | 2007-09-13 | Hugh Smyth | Dry powder inhaler with aeroelastic dispersion mechanism |
US20090241949A1 (en) * | 2008-03-27 | 2009-10-01 | Smutney Chad C | Dry powder inhalation system |
US20090308392A1 (en) * | 2008-06-13 | 2009-12-17 | Smutney Chad C | Dry Powder Inhaler and System for Drug Delivery |
US8424518B2 (en) | 2008-06-13 | 2013-04-23 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10751488B2 (en) | 2008-06-13 | 2020-08-25 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9192675B2 (en) | 2008-06-13 | 2015-11-24 | Mankind Corporation | Dry powder inhaler and system for drug delivery |
CN104689432A (en) * | 2008-06-13 | 2015-06-10 | 曼金德公司 | A dry powder inhaler and system for drug delivery |
US9339615B2 (en) | 2008-06-13 | 2016-05-17 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US8912193B2 (en) | 2008-06-13 | 2014-12-16 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9358352B2 (en) | 2008-06-13 | 2016-06-07 | Mannkind Corporation | Dry powder drug delivery system and methods |
US20100197565A1 (en) * | 2008-06-13 | 2010-08-05 | Smutney Chad C | Dry powder drug delivery system |
US8636001B2 (en) | 2008-06-13 | 2014-01-28 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US9393372B2 (en) | 2008-06-13 | 2016-07-19 | Mannkind Corporation | Dry powder drug delivery system |
US9446133B2 (en) | 2008-06-13 | 2016-09-20 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10342938B2 (en) | 2008-06-13 | 2019-07-09 | Mannkind Corporation | Dry powder drug delivery system |
US20090308391A1 (en) * | 2008-06-13 | 2009-12-17 | Smutney Chad C | Dry Powder Inhaler and System for Drug Delivery |
US9511198B2 (en) | 2008-06-13 | 2016-12-06 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US10201672B2 (en) | 2008-06-13 | 2019-02-12 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
US8499757B2 (en) | 2008-06-13 | 2013-08-06 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
US20090308390A1 (en) * | 2008-06-13 | 2009-12-17 | Smutney Chad C | Dry Powder Inhaler and System for Drug Delivery |
US9662461B2 (en) | 2008-06-13 | 2017-05-30 | Mannkind Corporation | Dry powder drug delivery system and methods |
US10675421B2 (en) | 2008-06-20 | 2020-06-09 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
US9943571B2 (en) | 2008-08-11 | 2018-04-17 | Mannkind Corporation | Use of ultrarapid acting insulin |
US9655850B2 (en) | 2008-12-29 | 2017-05-23 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US10172850B2 (en) | 2008-12-29 | 2019-01-08 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9220687B2 (en) | 2008-12-29 | 2015-12-29 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9983108B2 (en) | 2009-03-11 | 2018-05-29 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US9630930B2 (en) | 2009-06-12 | 2017-04-25 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
US9706944B2 (en) | 2009-11-03 | 2017-07-18 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
US8651104B2 (en) | 2010-12-07 | 2014-02-18 | Respira Therapeutics, Inc. | Bead-containing dry powder inhaler |
US10625034B2 (en) | 2011-04-01 | 2020-04-21 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
US10130709B2 (en) | 2011-06-17 | 2018-11-20 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9364436B2 (en) | 2011-06-17 | 2016-06-14 | Mannkind Corporation | High capacity diketopiperazine microparticles and methods |
US9610351B2 (en) | 2011-10-24 | 2017-04-04 | Mannkind Corporation | Methods and compositions for treating pain |
US10258664B2 (en) | 2011-10-24 | 2019-04-16 | Mannkind Corporation | Methods and compositions for treating pain |
US9233159B2 (en) | 2011-10-24 | 2016-01-12 | Mannkind Corporation | Methods and compositions for treating pain |
US11471623B2 (en) | 2012-02-21 | 2022-10-18 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
US10441733B2 (en) | 2012-06-25 | 2019-10-15 | Respira Therapeutics, Inc. | Powder dispersion devices and methods |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US20170128679A1 (en) * | 2014-06-27 | 2017-05-11 | Sergio BELFORTI | A powder inhaler device |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US20210016024A1 (en) * | 2018-04-16 | 2021-01-21 | Emphasys Importadora Exportadora E Distribuidora Ltda. | Dry Powder Inhaler |
US12042599B2 (en) * | 2018-04-16 | 2024-07-23 | Emphasys Importadora Exportadora E Distribuidora Ltda. | Dry powder inhaler |
USD1038374S1 (en) * | 2021-08-31 | 2024-08-06 | Nemera La Verpilliere | Nasal spray device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2549303A (en) | Inhaler for crystalline pencilllin or the like | |
US4570630A (en) | Medicament inhalation device | |
US2951644A (en) | Dispensing device | |
US3730179A (en) | Combination resuscitating, aspirating and gastric draining apparatus | |
US5855202A (en) | Aerosol holding chamber for a metered-dose inhaler | |
US5152284A (en) | Disposable inhaler with pre-pierced capsule | |
US2603215A (en) | Drug inhalator | |
US4198969A (en) | Suction-operated nebulizer | |
US2603216A (en) | Powder inhaler | |
US2573918A (en) | Device for dispensing medicaments | |
US2135052A (en) | Nasal douche | |
EP0388621A1 (en) | Inhaler with regular complete emptying of the capsule | |
US20090062855A1 (en) | Baby nebulizer | |
US2579280A (en) | Inhaler | |
US2524720A (en) | Eye-bathing device | |
US2503732A (en) | Inhalator | |
US2672865A (en) | Inhaler for medicinal substances | |
US2693805A (en) | Apparatus for administering therapeutic agents | |
WO1990013335A1 (en) | Disposable inhalation activated pulmonary medicine aerosol device | |
US3973566A (en) | Inhalation device | |
US3066669A (en) | Nebulizer | |
US2604094A (en) | Inhaler | |
US2592369A (en) | Powder inhaler | |
GB671582A (en) | Improvements in dispensers for medicinal and other powders | |
US3831603A (en) | Device for the oral administration of medicine |